Immune Response Markers for Cancer Vaccines Paint a Clearer Picture Genetic Engineering News Study results showed that BiovaxID active immunotherapy following treatment with rituximab combination chemotherapy induced nearly universal immune responses. These responses, which strongly correlated with overall survival (OS) in treated patients, ... |
